Runway Growth Finance Q2 2026: $44M Realized Loss from Restructurings, SWK Acquisition Closes, Co-CEO Appointed
RWAY sits 20% above its 52-week low of $5.19.
Summary
Runway Growth Finance reported a $44.4M realized loss in Q2 2026 from loan restructurings, offset by a $54.2M unrealized gain. The SWK acquisition closed, adding $239.7M in investments. A new Co-CEO was appointed and the credit facility was reduced to $425M.
Key Events · Earnings and Guidance · RWAY
-
$44.4M Realized Loss from Restructurings
The company recorded a $44.4 million realized loss on non-control/non-affiliate investments, primarily from the restructuring of loans to Blueshift Labs and Marley Spoon. This also triggered a $3.8 million reversal of previously accrued incentive fees.
-
$54.2M Unrealized Gain Offsets Losses
A $54.2 million net change in unrealized gain on non-control/non-affiliate investments was driven by the release of prior-period unrealized losses on the restructured Blueshift Labs and Marley Spoon loans, partially offset by new unrealized losses on the post-restructuring Marley Spoon investments.
-
SWK Acquisition Closed, Adding $239.7M in Investments
On April 6, 2026, Runway completed its acquisition of SWK Holdings, adding $239.7 million in investments at fair value and expanding the portfolio into life sciences. The deal was funded with $173.5 million in cash and 6.33 million shares of common stock.
-
Net Investment Income Rises to $18.2M
Net investment income increased to $18.2 million from $13.9 million a year ago, driven by higher interest income from a larger debt portfolio and lower incentive fees, partially offset by higher interest expense.
Analysis · RWAY · Unknown
Runway Growth Finance's Q2 2026 results reveal a $44.4 million realized loss, primarily from restructuring loans to Blueshift Labs and Marley Spoon, which also triggered a $3.8 million reversal of previously accrued incentive fees. The loss was partially offset by a $54.2 million unrealized gain from the release of prior-period marks on those same restructured investments. The quarter also reflects the April 6 acquisition of SWK Holdings, which added $239.7 million in investments at fair value and expanded the portfolio into life sciences. Net investment income rose to $18.2 million from $13.9 million a year ago, helped by lower incentive fees. The company also announced the appointment of a Co-CEO and a reduction in its credit facility commitments to $425 million. The stock trades at a deep discount to NAV of $11.91 per share.
At the time of this filing, RWAY was trading at $6.25 on NASDAQ in the Unknown sector, with a market capitalization of approximately $253.9M. The 52-week trading range was $5.19 to $11.20. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.